Free Trial

Steve Foots Purchases 5 Shares of Croda International Plc (LON:CRDA) Stock

Croda International logo with Basic Materials background

Croda International Plc (LON:CRDA - Get Free Report) insider Steve Foots acquired 5 shares of the business's stock in a transaction dated Friday, January 10th. The stock was acquired at an average cost of GBX 3,272 ($40.04) per share, with a total value of £163.60 ($200.20).

Croda International Trading Up 0.1 %

CRDA traded up GBX 3.10 ($0.04) during trading on Monday, hitting GBX 3,204.10 ($39.21). 213,056 shares of the stock traded hands, compared to its average volume of 224,113. The firm has a market capitalization of £4.47 billion, a P/E ratio of 2,738.55, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 30.70, a current ratio of 2.72 and a quick ratio of 2.25. The firm has a 50-day moving average of GBX 3,454.15 and a 200 day moving average of GBX 3,795.53. Croda International Plc has a 12-month low of GBX 3,191 ($39.05) and a 12-month high of GBX 5,124 ($62.70).

Croda International Company Profile

(Get Free Report)

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.

Recommended Stories

Insider Buying and Selling by Quarter for Croda International (LON:CRDA)

Should You Invest $1,000 in Croda International Right Now?

Before you consider Croda International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.

While Croda International currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

3 Stocks Insiders Are Selling, But Analysts Still Love
NVIDIA Unveils Game-Changing Tech, But Stock Dips
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines